As the American Society of Hematology’s 2017 congress approaches, there’s plenty to be excited about – not just in blood cancer, but in previously overlooked diseases such as sickle cell anaemi
Earlier this year pharmaphorum filmed a round table debate exploring how developments in personalised healthcare cancer treatments are defining the future for this area beyond oncology.
